SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VPHM - Viropharma Inc
An SI Board Since December 1998
Posts SubjectMarks Bans Symbol
2557 72 0 VPHM
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1507>> While I rant, why no archived CC? << God knows. Last I checked,scaram(o)uche-7/24/2003
1506What's with the exquisitely timed option grants? Lucky guess on p1b resultskeokalani'nui-7/24/2003
1505VPHM issues new options, exercise price 2.09, vesting in four equal annual instascaram(o)uche-7/24/2003
1504smallpox, etc.? the no "secondary" use provision shouldn't reallyscaram(o)uche-7/18/2003
1503>> Is it known if 371 (and their new candidates) have this target? <<scaram(o)uche-7/18/2003
1502Message 19118261 (still nothing from the Senate)scaram(o)uche-7/18/2003
1501For some reason -- and maybe I'm wrong -- de Rosen handed off the last questscaram(o)uche-7/17/2003
1500<i>Committed to polymerase target. </i> So is this the target that Biomaven-7/16/2003
1499updating the &$#%$* list....... news that might come through, near-term?? scaram(o)uche-7/16/2003
1498<i>in-license</i> Late last year, I was very critical of the concepscaram(o)uche-7/16/2003
1497Jim: You're welcome. Congrats on being on the correct side of this news. scaram(o)uche-7/16/2003
1496Rick thanks very much for that CC update. I sold out last week my long positionFindit-7/16/2003
1495McKinlay and Collett were on the call. HCV371 looks bad compared to candidates scaram(o)uche-7/16/2003
1494you and me both. picked up a few shares late last week @2.75 alas.mopgcw-7/16/2003
1493Damn, indeed. I took profits on VICL <b>last week</b> to get a few nigel bates-7/16/2003
1492Damn. Leaky, again.scaram(o)uche-7/15/2003
1491ViroPharma Announces Results of Hepatitis C Phase 1b Study Tuesday July 15, 4:45nigel bates-7/15/2003
1490same old, same old..... snugging the ask down on the bid (it's even our gscaram(o)uche-7/15/2003
1489news that might come through, near-term?? 1. HCV371, proof of concept. A biggscaram(o)uche-7/13/2003
1488emphasis mine...... bayarea.com Bioterrorism field risky, so firms are being cscaram(o)uche-7/13/2003
1487J Med Chem. 2003 Jul 17;46(15):3181-3184. An Orally Bioavailable Oxime Ether scaram(o)uche-7/12/2003
1486A block! 100K at 9:43. I've been on vacation, but, before, there was a deascaram(o)uche-7/10/2003
1485>> Well, if that's worst case, what is the THIRD molecule, addressing scaram(o)uche-7/10/2003
1484<i>In June 2003, we amended our collaboration agreement with Wyeth to, amoscaram(o)uche-7/8/2003
1483>> expects to determine, within the next few weeks, the activity of the coscaram(o)uche-7/8/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News